| Advaxis, Inc . , (OTCBB: ADXS) , a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reports that Thomas Moore, CEO & Chairman of Advaxis, was interviewed by Malini Chatterjee, Ph.D., Director of Research at OneMedPlace, to discuss the preliminary safety and survival data from the ongoing ADXS-HPV Phase 2 Trial in patients with recurrent/refractory cervical cancer in India that were presented at the World Cancer Immunotherapy Conference in San Diego o...continued ADXS listeria Healthcare Drugs |
Thursday, January 26, 2012
Advaxis CEO Tom Moore Interviewed by OneMedPlace Regarding Preliminary Data
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment